Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Discontinued OperationsCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

SOPHiA GENETICS (SOPH) Free Cash Flow (2020 - 2025)

Historic Free Cash Flow for SOPHiA GENETICS (SOPH) over the last 6 years, with Q3 2025 value amounting to -$8.6 million.

  • SOPHiA GENETICS's Free Cash Flow fell 351.53% to -$8.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$37.9 million, marking a year-over-year increase of 1702.85%. This contributed to the annual value of -$43.7 million for FY2024, which is 1412.55% up from last year.
  • According to the latest figures from Q3 2025, SOPHiA GENETICS's Free Cash Flow is -$8.6 million, which was down 351.53% from -$8.1 million recorded in Q2 2025.
  • SOPHiA GENETICS's Free Cash Flow's 5-year high stood at -$8.1 million during Q2 2025, with a 5-year trough of -$22.2 million in Q3 2022.
  • For the 5-year period, SOPHiA GENETICS's Free Cash Flow averaged around -$12.9 million, with its median value being -$12.4 million (2023).
  • In the last 5 years, SOPHiA GENETICS's Free Cash Flow tumbled by 6701.49% in 2022 and then surged by 4584.87% in 2023.
  • Over the past 5 years, SOPHiA GENETICS's Free Cash Flow (Quarter) stood at -$15.3 million in 2021, then soared by 40.73% to -$9.0 million in 2022, then tumbled by 37.3% to -$12.4 million in 2023, then rose by 15.77% to -$10.5 million in 2024, then increased by 17.57% to -$8.6 million in 2025.
  • Its Free Cash Flow was -$8.6 million in Q3 2025, compared to -$8.1 million in Q2 2025 and -$10.7 million in Q1 2025.